US20130053814A1 - Device - Google Patents

Device Download PDF

Info

Publication number
US20130053814A1
US20130053814A1 US13/522,481 US201113522481A US2013053814A1 US 20130053814 A1 US20130053814 A1 US 20130053814A1 US 201113522481 A US201113522481 A US 201113522481A US 2013053814 A1 US2013053814 A1 US 2013053814A1
Authority
US
United States
Prior art keywords
spike assembly
device
receptacle
inner sleeve
inner
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/522,481
Inventor
Andreas Mueller-Beckhaus
Kevin Prosise
Edward Cheng
Peter Kramer
Patrick Ryan
Andrew Coats
Robert Dyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer HealthCare LLC
Original Assignee
Bayer HealthCare LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US29567910P priority Critical
Application filed by Bayer HealthCare LLC filed Critical Bayer HealthCare LLC
Priority to PCT/US2011/021580 priority patent/WO2011088471A1/en
Priority to US13/522,481 priority patent/US20130053814A1/en
Assigned to BAYER HEALTHCARE LLC reassignment BAYER HEALTHCARE LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: COATS, ANDREW, PROSISE, KEVIN, RYAN, PATRICK, DYER, ROBERT, CHENG, EDWARD, MUELLER-BECKHAUS, ANDREAS, KRAMER, PETER
Publication of US20130053814A1 publication Critical patent/US20130053814A1/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44304701&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20130053814(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application status is Abandoned legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/14Details, e.g. provisions for hanging or shape retaining means; Accessories therefor, e.g. inlet or outlet ports, filters or caps
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2096Combination of a vial and a syringe for transferring or mixing their contents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/14Details, e.g. provisions for hanging or shape retaining means; Accessories therefor, e.g. inlet or outlet ports, filters or caps
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2006Piercing means
    • A61J1/201Piercing means having one piercing end
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/14Details, e.g. provisions for hanging or shape retaining means; Accessories therefor, e.g. inlet or outlet ports, filters or caps
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2048Connecting means
    • A61J1/2051Connecting means having tap means, e.g. tap means activated by sliding
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/14Details, e.g. provisions for hanging or shape retaining means; Accessories therefor, e.g. inlet or outlet ports, filters or caps
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2048Connecting means
    • A61J1/2065Connecting means having aligning and guiding means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/14Details, e.g. provisions for hanging or shape retaining means; Accessories therefor, e.g. inlet or outlet ports, filters or caps
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2068Venting means
    • A61J1/2075Venting means for external venting

Abstract

The present application is directed to devices. The device may used for connecting a closed receptacle and a container, such as a syringe.

Description

    REFERENCE TO RELATED APPLICATIONS
  • This application claims priority to U.S. Provisional Application Ser. No. 61/295,679 filed on Jan. 15, 2010 and is hereby incorporated by reference for all purposes.
  • FIELD OF THE INVENTION
  • The present application is directed to devices. The device may be used for connecting a closed receptacle and a container, such as a syringe. As an example, the device may be used to reconstitute a drug product, or to combine two separate components.
  • BACKGROUND
  • For certain chronic diseases such as hemophilia, diabetes, and multiple sclerosis, it is often necessary for patients suffering from these diseases to self-administer their medication. Often, these medications are available in a lyophilized form; and therefore, it is necessary for the patient or caregiver to reconstitute this medication. Reconstitution may require the use of a syringe to introduce diluent into a vial containing the medication, and possibly subjecting the patient or caregiver to accidental needle sticks. Hence, there is a need for a device that is safe to use for both patients and caregivers.
  • Another factor to consider for such a device is ease of use. For patients and caregivers, a complicated device may lead to reconstitution failure, contamination, or incorrect dosing. Similarly, untrained health care professionals, particularly in an emergency situation, may also face the same problems. Furthermore, a complicated device may have an impact on patient compliance. Therefore, it would be beneficial to patients, caregivers, and untrained health care professionals to have access to a convenient, safe, and easy-to-use device.
  • Other factors to consider are waste of medication and unnecessary costs. That is, a device that is easy-to-use may limit the loss of medication due to improper reconstitution. Also, for prevention of contamination, the device may be a single use device, and as such may include a mechanism to prevent reuse of the device.
  • Accordingly, there is a need for a safe, convenient, and easy-to-use device that limits the potential for reconstitution failure, contamination, or incorrect dosing and thus would be beneficial to patients and caregivers.
  • SUMMARY OF THE INVENTION
  • The invention is directed to a device comprising: a receptacle including an opening surrounded by a neck; an inner sleeve including a first end, a second end, and an inner bore having a central aperture, the first end having a flexible skirt that is secured to the receptacle, the flexible skirt including one or more webbed protrusions extending outwardly from the inner bore, the webbed protrusions including one or more tabs that grip the neck of the receptacle; an outer sleeve including a first end and a second end, the outer sleeve surrounding the flexible skirt of the inner sleeve which pushes against the flexible skirt to secure the inner sleeve to the receptacle; a stopper located in the opening of the neck of the receptacle, the stopper including a portion capable of being perforated; a spike assembly adapted to slide along the inner bore of the inner sleeve, the spike assembly having a shaft capable of perforating the stopper; an outer cover surrounding the spike assembly and the inner sleeve and having an inner projection member extending downwardly from the top of the outer cover; a locking mechanism including a clip coaxially aligned with the shaft of the spike assembly, the clip capable of flexing to lock the spike assembly in an activated position in which the shaft is perforating the stopper; and an actuating mechanism for moving the spike assembly into the activated position comprising a first helical path located on an outer surface of the spike assembly and a corresponding second helical path located on the inner projection member of the outer cover, the first and second helical paths interacting to rotate and push the spike assembly downwardly into the activated position so the shaft of the spike assembly perforates the stopper.
  • In one embodiment, the outer sleeve of the device may include a lip which fits underneath the webbed protrusions of the flexible skirt to hold the flexible skirt in place. The outer sleeve may also include one or more slots and/or one or more ridges. The clip of the locking mechanism further may include one or more protrusions. The spike assembly of the device further may include a male element for receiving a second receptacle. The male element may include an inner bore and an outer surface including a thread. The second receptacle of the device may be a syringe. The spike assembly of the device may also include one or more tabs which engage the one or more openings of the inner sleeve.
  • In another embodiment, the spike assembly may include a filtering mechanism and at least one channel for establishing fluid communication between the inside of the receptacle and the inner bore of the male element. The shaft of the spike assembly may include a branched channel and an air channel. The locking mechanism of the device may be located in the inner sleeve. The locking mechanism may be secured to the spike assembly. The spike assembly may include at least one rib located on the surface of the spike assembly for aligning the spike assembly with the inner sleeve. The outer cover of the device may include at least one finger grip.
  • In a further embodiment, the device may comprise a drug product or pharmaceutical composition. The device may be a single use device. The device may also include a use indicator and/or a tamper-evidence indicator. The tamper-evidence indicator may be a seal, holographic label, a tab, or the like.
  • The invention is also directed to a method of actuating a device comprising providing a spike assembly adapted to slide along an inner bore of the inner sleeve, the spike assembly having a shaft capable of perforating the stopper, the spike assembly further including a first helical path on an outer surface; providing an outer cover surrounding the spike assembly and the inner sleeve and having an inner projection member extending downwardly from the top of the outer cover, the outer cover further including a second helical path located on the inner projection member; rotating the outer cover so the second helical path interacts with the first helical path to rotate and push the spike assembly downwardly into an activated position in which the shaft of the spike assembly perforates the stopper; and locking the spike assembly in the activated position by a locking mechanism.
  • In additional embodiments of the device, the device may be activated by a user rotating the outer cover and then pushing the outer cover downward which would then cause the spike assembly to perforate the stopper or the user may simply push the outer cover downward to cause the spike assembly to perforate the stopper. In another embodiment, the device may include a locking mechanism comprising a barb lock as a means to prevent the upward movement of the spike assembly after downward movement of the spike assembly has occurred.
  • The invention is also directed to a kit containing a device and a prefilled diluent syringe. The kit may further comprise an infusion set. In another embodiment, the kit may also comprise an alcohol swab, a cotton pad, and a bandage.
  • In another embodiment, the device may function as a channel between two compartments (e.g., sterile vial or bag). For example, the device may maintain the separation of two components prior to activation. Upon activation of the device, the channel is opened, allowing the transfer of the two components, and thereby combining the components.
  • DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is an illustration of the device.
  • FIG. 2 is an expanded view of the stopper and receptacle.
  • FIG. 3A is an expanded view of the inner sleeve. FIGS. 3B and 3C are perspective views of the inner sleeve.
  • FIG. 4A is an expanded view of the outer sleeve. FIGS. 4B and 4C are perspective views of the outer sleeve.
  • FIG. 5A is an expanded view of the spike assembly illustrating the locking mechanism. FIG. 5B is a perspective view of the clip of the locking mechanism and FIG. 5C is a perspective view of the inner sleeve.
  • FIGS. 6A, 6B, and 6C are perspective views of the spike assembly. FIGS. 6D and 6E are expanded views of the spike assembly illustrating a filtering mechanism.
  • FIG. 7A is an expanded view of the spike assembly illustrating the air and fluid channels. FIG. 7B is an expanded view of the shaft.
  • FIG. 8 is an expanded view of the shaft illustrating the air and fluid channels.
  • FIG. 9 is an expanded view of the spike assembly illustrating the activating mechanism.
  • FIG. 10A is expanded view of the outer cover and FIGS. 10B and 10C are perspective views of the outer cover. FIGS. 10D and 10E are perspective views of the ratcheting mechanism.
  • FIG. 11A exemplifies the attachment of the device to a vial and FIG. 11B is a perspective view of the attachment.
  • FIG. 12 is expanded view of the device illustrating the elements of the device.
  • DESCRIPTION OF THE INVENTION
  • It is to be understood that this invention is not limited to the particular device or parts described and as such may vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to limit the scope of the present invention which will be limited only by the appended claims.
  • It must be noted that as used herein and in the appended claims, the singular forms “a,” “and,” and “the” include plural reference unless the context clearly dictates otherwise. Thus, for example, reference to “a tab” is a reference to one or more tabs and includes equivalents thereof known to those skilled in the art, and so forth. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood to one of ordinary skill in the art to which this invention belongs.
  • The present invention is directed to a device 10 (FIG. 1). The device 10 may include a receptacle 12 for storing a first component such as, a pharmaceutical composition or a drug product. The receptacle may be a bottle or vial, for example, a glass vial, or a bag, for example, an IV bag. The receptacle 12 may include an opening 16 surrounded or partially surrounded by a neck 14. The neck 14 may also include a lip 15. The opening 16 in the neck 14 allows for a second component, such as a liquid (e.g., a diluent), to be introduced into the receptacle 12 and mixed with the first component. A stopper 18 may be positioned in the opening 16 of the neck 14 to block access to the receptacle 12. The stopper 18 may be, for example, a two-leg, three-leg, or round bottom stopper and made of a relatively non-rigid material, for example, a polymer such as an elastomer. The stopper 18 may include a top portion 20 located against the lip 15, and a bottom portion 22 located within the opening of the neck 14. The top portion 20 may be capable of being perforated, thereby allowing access to the receptacle 12. See FIG. 2.
  • The device 10 may further include an inner sleeve 24 secured to the neck 14 of the receptacle 12. The inner sleeve 24 may have a first end 25, which is secured to the neck 14 of the receptacle 12, a second end 30 located opposite the first end 25, and an inner bore 34 with a central aperture 35. The first end 25 of the inner sleeve 24 has a flexible skirt 26 that is secured to the receptacle 12 and may surround at least a portion of the stopper 18. The flexible skirt 26 may include one or more webbed protrusions 27 which extend outwardly from the inner bore 34. The webbed protrusions 27 may include one or more tabs 28 which grip the neck 14 of the receptacle 12. As such, the inner sleeve 24 can expand to fit over the lip 15 of the neck 14 during the capping process, and then contract to securely mate with the neck 14. The inner sleeve 24 may further include a step portion 31 located between the first end 25 and the second end 30, thereby separating the first end 25 from the second end 30. The inner sleeve 24 may also include an O-ring 32 located at the step portion 31. The first end 25 of the inner sleeve 24 may have a larger diameter than the second end 30 of the inner sleeve 24. The second end 30 may also include one or more openings 33 which may be used to secure the spike assembly 50 at the second end 30 of the inner sleeve 24. See FIG. 3.
  • The first end 25 of the inner sleeve 24 may be surrounded by an outer sleeve 40. The outer sleeve 40 surrounds the flexible skirt 26 of the inner sleeve 24 and pushes against the flexible skirt 26 to secure the inner sleeve 24 to the receptacle 12. The outer sleeve may have a first end 41 and a second end 42. The first end 41 of the outer sleeve 40 may include a lip 43 which fits underneath the webbed protrusions 27 of the flexible skirt 26 to hold the flexible skirt 26 in place. The second end 42 of the outer sleeve 40 may also include one or more slots 44 and a ridge 45. The slots 44 and ridge 45 of the outer sleeve 40 may be used to engage and secure the outer cover 80. The outer sleeve 40 may further include a textured surface to facilitate gripping the device 10 by a user. The outer sleeve 40 may also include one or more finger grips. See FIG. 4.
  • The device 10 may further comprise a spike assembly 50 adapted to slide along the inner bore 34 of the inner sleeve 24. The spike assembly 50 may be located at the second end 30 of the inner sleeve 24. The spike assembly 50 may further comprise a tab 52 which engages an opening 33 on the inner sleeve 24 and secures the spike assembly 50 at the second end 30 of the inner sleeve 24. The spike assembly 50 may also include one or more ribs 65 located on the surface of the spike assembly 50. The one or more ribs 65 of the spike assembly 50 allow for alignment with the one or more grooves 66 of the inner sleeve 24. The spike assembly 50 includes a shaft 51 capable of perforating a stopper 18. The shaft 51 extends downward in a direction towards the stopper 18. The shaft 51 may include a pointed end 53 for piercing the top portion 20 of the stopper 18, thereby allowing the shaft 51 access to the receptacle 12. The pointed end 53 may be straight or angled. In one embodiment, the shaft 51 may be elliptical-shaped (e.g., oval shaped). In another embodiment, the shaft 51 may have a cylindrical shape or a rectangular shape. See FIG. 5.
  • The device 10 may include a locking mechanism 54 for preventing upward movement of the spike assembly 50 after downward movement of the spike assembly 50 has occurred. In this manner, the device 10 may be prevented from multiple uses by restraining the spike assembly 50 in an engaged position, that is, when the shaft 51 pierces the stopper 18. The locking mechanism may be located in the inner sleeve. The locking mechanism 54 includes a clip 55 coaxially aligned with the shaft 51 of the spike assembly 50. The clip 55 is capable of flexing to lock the spike assembly 50 in an activated position in which the shaft 51 has perforated the stopper 18. The clip 55 engages a ridge 29 located on the inner bore 34 of the inner sleeve 24. Once engaged, the clip 55 prevents the spike assembly 50 from moving in an upward direction. The clip 55 may be in elliptical or rectangular shape and made of any flexible material, for example, plastic. The clip 55 may further comprise one or more protrusions. See FIG. 5.
  • The locking mechanism 54 ensures a smooth downward motion of the spike assembly 50 with low actuation force and prevents reuse of the device 10 by retaining the spike assembly 50 in a downward position due to a high retaining force (relative to the actuation force). The locking mechanism 54 may prevent return motion at any point during the downward movement of the shaft 51.
  • The spike assembly 50 may include a male element 57 extending from the top surface of the spike assembly 50 in an upward direction opposite the shaft 51. The male element 57 may be configured to receive a second receptacle, such as a syringe. The male element 57 may include an inner bore 58 and an outer surface 59. The outer surface 59 may include a thread 61 for mating with the second receptacle. For example, a user may fasten a second receptacle (e.g., threaded syringe) to the thread 61 on the outer surface 59 of the male element 57. The user would continue to turn the second receptacle until the second receptacle makes contact with the top surface 60 of the spike assembly 50. The user would then know the second receptacle is fully secured to the male element 57. See FIG. 6.
  • The spike assembly 50 may further include one or more filtering mechanisms. For example, a fluid filter may be located within the inner bore 58 of the spike assembly 50 to filter any liquid that is introduced into the spike assembly 50. Furthermore, an air filter 56 may be located on the spike assembly 50 to filter any air that is introduced into the receptacle 12. The air filter 56 may be made from any of a variety of materials (e.g., nylon, PVDF, PE). The air filter 56 may also comprise pores (e.g., 0.001-200 μm). See FIG. 6.
  • The shaft 51 of the spike assembly 50 may include a first longitudinal channel 62. The first longitudinal channel 62 establishes communication between the receptacle 12 and the inner bore 58 of the male element 57. The first channel 62 may allow fluid to pass through the shaft 51 of the spike assembly 50 and into the receptacle 12. The first channel 62 may branch into two or more channels. For example, the first channel 62 may branch (or trifurcate) into three channels 62 a-c. See FIG. 7.
  • The shaft 51 of the spike assembly 50 may include a second longitudinal channel 63. The end of the second channel 63 may be located opposite the pointed end 53 of the shaft 51 may interface to an air channel return. The air channel return interfaces with an air filter 56. The second channel 63 functions as an air path to allow air to travel out of the receptacle 12 through the shaft 51 of the spike assembly 50, into the air channel return, through the filter 56, and then through a vent 64 located on the spike assembly 50. The air exiting the vent 64 is vented to the atmosphere surrounding the device 10. See FIGS. 6 and 8.
  • The device 10 may also include an actuating mechanism which moves the spike assembly 50 into the activated position. The actuating mechanism may comprise a first helical path 70 located on an outer surface of the spike assembly 50 and a corresponding second helical path 81 located on the inner projection member of the outer cover 80, the first and second helical paths (70, 81) interacting to rotate and push the spike assembly 50 downwardly into the activated position so the shaft 51 of the spike assembly 50 perforates the stopper 18. See FIG. 9.
  • In order to use the device 10, a user may rotate the outer cover 80 a given number of degrees until the shaft 51 of the spike assembly 50 perforates the stopper 18. In one embodiment, as the user rotates the outer cover 80, the first and second helical paths (70, 81) interact to push the spike assembly 50 downward into the activated position and the clip 55 of the locking mechanism 54 engages the ridge 29 of the inner bore 34 of the inner sleeve 24, preventing the spike assembly 50 from moving in the upward direction. This mechanism may provide tactile and/or audible feedback for the user so that the user would know when the spike assembly 50 has completed the downward direction and activation has occurred. The device may also include alignment markers or color indicators located on the outer cover 80 and outer sleeve 40 as visual feedback for the user. For example, the outer cover 80 may include a slot or window which would reflect a color change when the device was activated (e.g., red to green).
  • In operation, and by way of example, as the spike assembly 50 travels in a direction towards the stopper 18, the feedback mechanism provides tactile feedback as the clip 55 of the locking mechanism 54 travels past the ridge 29 of the inner bore 34 of the inner sleeve 24. The tactile feedback may be felt by the user. Moreover, as the clip 55 of the locking mechanism 54 travels past the ridge 29 of the inner bore 34, a sound may be made such that the feedback mechanism also provides audible feedback.
  • As mentioned above, the device 10 may include a feedback mechanism that provides a user of the device 10 with feedback regarding operation of the device 10. For example, the feedback may indicate that the shaft 51 has traveled an optimum distance into the stopper 18. Alternatively, or in combination, the feedback may indicate that the spike assembly 50 has traveled an optimum distance within the inner sleeve 24 and that the user should not push the spike assembly 50 any further. Other examples of the feedback provided by the feedback mechanism are also possible.
  • The surface 82 of the outer cover 80 may include direction markers 83 to indicate to a user which direction to turn the outer cover 80. The surface 82 of the outer cover 80 may further include alignment markers to indicate to the user when the actuating mechanism is aligned. The surface 82 of the outer cover 80 may be textured to facilitate gripping and rotating the cover 80 by a user. For example, the outer cover may include at least one finger grip. See FIG. 10.
  • In one embodiment, the device 10 may include a ratcheting mechanism to prevent the reverse motion of the outer cover 80, that is, preventing the return of the device 10 to its starting position after partial activation and thus, avoid potential contamination. One or more tabs 84 located on the first end 86 of the outer cover 80 align with the one or more slots 44 of the outer sleeve 40. The first end 86 of the outer cover 80 also includes one or more ribs 85 which engage the ridge 45 of the outer sleeve 40. As the outer cover 80 rotates, each rib 85 deflects over the ridge 45 and the rotation of the outer cover 80 cannot be reversed. See FIG. 10.
  • In a further embodiment, the device 10 may include a tamper-proof mechanism to indicate to a user whether the device 10 has been used. The tamper-proof mechanism may comprise any type of indicator, for example, a seal (e.g., perforated or frangible seal), a holographic label, or a tab.
  • In operation, the device 10 is in a disengaged position, that is, the shaft 51 of the spike assembly 50 is not piercing the stopper. To activate the device 10, a user may rotate the outer cover 80, for example, a given number of degrees, which pushes the spike assembly 50 downward toward the stopper 18. The shaft 51 of the spike assembly 50 may pierce the stopper 18, allowing access to the opening 16 of the receptacle 12. The contents of a second receptacle (e.g., pre-filled syringe) may then be introduced into the receptacle 12 to mix with the drug product. The mixed contents may then be pulled back into the second receptacle. A needle may then be secured to the second receptacle, and the complete and active drug product may be administered to a patient.
  • Assembly of the first end 25 of the inner sleeve 24 to the receptacle 12 may be carried out using various methods. For example, the inner sleeve 24 slides over the stopper 18 allowing the flexible skirt 26 to expand as the flexible skirt 26 passes over the lip 15 of the receptacle 12, and then the flexible skirt 26 may contract after passing over the lip 15 and the tabs 28 of the flexible skirt 26 grip the neck 14 of the receptacle 12. Furthermore, the outer sleeve 40 holds the flexible skirt 26 in place.
  • The device 10 may be activated by a user rotating the outer cover 80 and then pushing the outer cover 80 downward which would then cause the spike assembly 50 to perforate the stopper 18, or the user may simply push the outer cover 80 downward to cause the spike assembly 50 to perforate the stopper 18.
  • The device 10 may include a locking mechanism 54 comprising a barb lock as a means to prevent the upward movement of the spike assembly 50 after downward movement of the spike assembly 50 has occurred. The barb lock may be located in the inner sleeve and would be capable of flexing to lock the spike assembly 50 in an activated position in which the shaft 51 has perforated the stopper 18. For example, the barb lock may comprise spikes which would engage the side of the inner bore 34 of the inner sleeve 24. Once engaged, the barb lock prevents the spike assembly 50 from moving in an upward direction.
  • The device 10 may function as a channel 62 between two compartments (e.g., sterile vial or bag). For example, the device may maintain the separation of two components prior to activation. Upon activation of the device, the channel is opened, allowing the transfer of the two components, and thereby combining the components. In addition, the outer cover 80 and the inner sleeve 24 provide physical barriers, protecting the components from contamination.
  • Attachment
  • The device 10 may be attached to a receptacle 12 (e.g., a vial) by manual means or by automation. As an example of automation, the device 10 may be attached to a vial during a capping process. This process may involve applying a force to the top of the device 10 and transferring that force to the outer sleeve 40. The force drives the outer sleeve 40 downward, which causes the flexible skirt 26 to crimp around the lip 15 of the vial, the outer sleeve 40 locks over the flexible skirt 26, and the stopper 18 is compressed against the vial. FIG. 11A exemplifies the application of a force to the top of the device 10 and transferring that force to the outer sleeve 40 and FIG. 11B exemplifies the flexible skirt 26 crimping around the lip 15 of the vial.
  • Pharmaceutical Compositions
  • The application also provides, in part, a device comprising a pharmaceutical composition. The compositions may be suitable for in vivo administration and are pyrogen free. The compositions may also comprise a pharmaceutically acceptable carrier. The phrase “pharmaceutically or pharmacologically acceptable” refers to molecular entities and compositions that do not produce adverse, allergic, or other untoward reactions when administered to an animal or a human. As used herein, pharmaceutically acceptable carrier includes any and all solvents, dispersion media, coatings, antibacterial and antifungal agents, isotonic and absorption delaying agents, and the like. The use of such media and agents for pharmaceutically active substances is well known in the art. Supplementary active ingredients also may be incorporated into the compositions.
  • A drug product may be prepared for administration as solutions of free base or pharmacologically acceptable salts in water, suitably mixed with a surfactant, such as hydroxypropylcellulose. Dispersions also may be prepared in glycerol, liquid polyethylene glycols, and mixtures thereof, and in oils. Under ordinary conditions of storage and use, these preparations contain a preservative to prevent the growth of microorganisms.
  • The pharmaceutical forms, suitable for injectable use, include sterile aqueous solutions or dispersions and sterile powders for the extemporaneous preparation of sterile injectable solutions or dispersions. The form should be sterile and should be fluid to the extent that easy syringability exists. It should be stable under the conditions of manufacture and storage and should be preserved against the contaminating action of microorganisms, such as bacteria and fungi. The carrier may be a solvent or dispersion medium containing, for example, water, ethanol, polyol (e.g., glycerol, propylene glycol, and liquid polyethylene glycol, and the like) sucrose, L-histidine, polysorbate-80, or suitable mixtures thereof, and vegetable oils. The prevention of the action of microorganisms may be brought about by various antibacterial an antifungal agents, for example, parabens, chlorobutanol, phenol, sorbic acid, thimerosal, and the like. The injectable compositions may include isotonic agents, for example, sugars or sodium chloride.
  • Sterile injectable solutions may be prepared by incorporating a drug product (e.g., FVII, FVIII, FIX, insulin, interferon) in the required amount in the appropriate solvent with various of the other ingredients enumerated above, as required, followed by filtered sterilization.
  • Generally, dispersions may be prepared by incorporating the various sterilized active ingredients into a sterile vehicle that contains the basic dispersion medium and the required other ingredients from those enumerated above. In the case of sterile powders for the preparation of sterile injectable solutions, methods of preparation include, for example, vacuum-drying and freeze-drying techniques that yield a powder of the active ingredient plus any additional desired ingredient from a previously sterile-filtered solution thereof.
  • Upon formulation, solutions may be administered in a manner compatible with the dosage formulation and in such amount as is therapeutically effective. “Therapeutically effective amount” is used herein to refer to the amount of a drug product that is needed to provide a desired level of the drug product in the bloodstream or in the target tissue. The precise amount will depend upon numerous factors, for example, the particular drug product, the components and physical characteristics of the therapeutic composition, intended patient population, mode of delivery, individual patient considerations, and the like, and can readily be determined by one skilled in the art, based upon the information provided herein.
  • The formulations may be easily administered in a variety of dosage forms, such as injectable solutions, and the like. For parenteral administration in an aqueous solution, for example, the solution should be suitably buffered, if necessary, and the liquid diluent first rendered isotonic with sufficient saline or glucose. These particular aqueous solutions are especially suitable for intravenous, intramuscular, subcutaneous and intraperitoneal administration.
  • The frequency of dosing will depend on the pharmacokinetic parameters of the agents and the routes of administration. The optimal pharmaceutical formulation may be determined by one of skill in the art depending on the route of administration and the desired dosage (see, e.g., Remington's Pharmaceutical Sciences, Mack Publishing Co., Easton, Pa., 20th edition, 2000, incorporated herein by reference). Exemplary dosing schedules include, without limitation, administration five times a day, four times a day, three times a day, twice daily, once daily, three times weekly, twice weekly, once weekly, twice monthly, once monthly, and any combination thereof.
  • The composition may also include an antimicrobial agent for preventing or deterring microbial growth. Non-limiting examples of antimicrobial agents suitable for the present invention include benzalkonium chloride, benzethonium chloride, benzyl alcohol, cetylpyridinium chloride, chlorobutanol, phenol, phenylethyl alcohol, phenylmercuric nitrate, thimersol, and combinations thereof.
  • An antioxidant may be present in the composition as well. Antioxidants may be used to prevent oxidation, thereby preventing the deterioration of the preparation. Suitable antioxidants for use in the present invention include, for example, ascorbyl palmitate, butylated hydroxyanisole, butylated hydroxytoluene, hypophosphorous acid, monothioglycerol, propyl gallate, sodium bisulfite, sodium formaldehyde sulfoxylate, sodium metabisulfite, and combinations thereof.
  • A surfactant may be present as an excipient. Exemplary surfactants include: polysorbates such as Tween®-20 (polyoxyethylenesorbitan monolaurate) and Tween®-80 (polyoxyethylenesorbitan monooleate) and pluronics such as F68 and F88 (both of which are available from BASF, Mount Olive, N.J.); sorbitan esters; lipids such as phospholipids such as lecithin and other phosphatidylcholines, phosphatidylethanolamines, fatty acids and fatty esters; steroids such as cholesterol; and chelating agents such as EDTA, zinc and other such suitable cations.
  • Acids or bases may be present as an excipient in the composition. Non-limiting examples of acids that may be used include hydrochloric acid, acetic acid, phosphoric acid, citric acid, malic acid, lactic acid, formic acid, trichloroacetic acid, nitric acid, perchloric acid, phosphoric acid, sulfuric acid, fumaric acid, and combinations thereof. Examples of suitable bases include, without limitation, sodium hydroxide, sodium acetate, ammonium hydroxide, potassium hydroxide, ammonium acetate, potassium acetate, sodium phosphate, potassium phosphate, sodium citrate, sodium formate, sodium sulfate, potassium sulfate, potassium fumerate, and combinations thereof.
  • The amount of any individual excipient in the composition may vary depending on the activity of the excipient and particular needs of the composition. Typically, the optimal amount of any individual excipient may be determined through routine experimentation, that is, by preparing compositions containing varying amounts of the excipient (ranging from low to high), examining the stability and other parameters, and then determining the range at which optimal performance is attained with no significant adverse effects. Generally, the excipient may be present in the composition in an amount of about 1% to about 99% by weight, from about 5% to about 98% by weight, from about 15 to about 95% by weight of the excipient, with concentrations less than 30% by weight. These foregoing pharmaceutical excipients along with other excipients are described in “Remington: The Science & Practice of Pharmacy,” 19 ed., Williams & Williams, (1995); the “Physician's Desk Reference,” 52 ed., Medical Economics, Montvale, N.J. (1998); and Kibbe, A. H., Handbook of Pharmaceutical Excipients, 3 Edition, American Pharmaceutical Association, Washington, D.C., 2000.
  • Kits
  • The invention further provides kits that may be used, for example, by patients or healthcare providers for reconstituting a drug prior to administration of the drug to a subject in need of treatment. The kit may comprise a device as described herein and a prefilled diluent syringe. The kit may further comprise an infusion set. In another embodiment, the kit may also comprise an alcohol swab, a cotton pad, and a bandage.
  • The devices, methods, and materials described herein are intended to be representative examples of the invention, and it will be understood that the scope of the invention is not limited by the scope of the examples. Those skilled in the art will recognize that the invention may be practiced with variations on the disclosed devices, methods, and materials, and such variations are regarded as within the ambit of the invention.

Claims (20)

1. A device comprising:
a receptacle including an opening surrounded by a neck;
an inner sleeve including a first end, a second end, and an inner bore having a central aperture, the first end having a flexible skirt that is secured to the receptacle, the flexible skirt including one or more protrusions extending outwardly from the inner bore,
an outer sleeve including a first end and a second end, the outer sleeve surrounding the flexible skirt of the inner sleeve which pushes against the flexible skirt to secure the inner sleeve to the receptacle;
a stopper located in the opening of the neck of the receptacle, the stopper including a portion capable of being perforated;
a spike assembly adapted to slide along the inner bore of the inner sleeve, the spike assembly having a shaft capable of perforating the stopper;
an outer cover surrounding the spike assembly and the inner sleeve and having an inner projection member extending downwardly from the top of the outer cover;
a locking mechanism including a clip coaxially aligned with the shaft of the spike assembly, the clip capable of flexing to lock the spike assembly in an activated position in which the shaft is perforating the stopper; and
an actuating mechanism for moving the spike assembly into the activated position.
2. The device of claim 1, wherein the outer sleeve includes a lip which fits underneath the webbed protrusions of the flexible skirt to hold the flexible skirt in place.
3. The device of claim 1, wherein the outer sleeve includes one or more slots and one or more ridges.
4. The device of claim 1, wherein the clip of the locking mechanism further includes one or more protrusions.
5. The device of claim 1, wherein the spike assembly further includes a male element for receiving a second receptacle.
6. The device of claim 5, wherein the male element includes an inner bore and an outer surface including a thread.
7. The device of claim 5, wherein the second receptacle is a syringe.
8. The device of claim 1, wherein the spike assembly further includes one or more tabs which engage the one or more openings of the inner sleeve.
9. The device of claim 5, wherein the spike assembly includes a filtering mechanism and at least one channel for establishing fluid communication between the inside of the receptacle and the inner bore of the male element.
10. The device of claim 1, wherein the shaft of the spike assembly has a branched fluid channel and one air channel.
11. The device of claim 1, wherein the locking mechanism is located in the inner sleeve.
12. The device of claim 1, wherein the locking mechanism is secured to the spike assembly.
13. The device of claim 1, wherein the spike assembly includes at least one rib located on the surface of the spike assembly for aligning the spike assembly with the inner sleeve.
14. The device of claim 1, wherein the outer cover includes at least one finger grip.
15-29. (canceled)
30. A method of actuating a device having a receptacle, an inner sleeve secured to the receptacle, and a stopper located between the receptacle and the inner sleeve, the method comprising:
providing a spike assembly adapted to slide along an inner bore of the inner sleeve, the spike assembly having a shaft capable of perforating the stopper, the spike assembly further including a first helical path on an outer surface;
providing an outer cover surrounding the spike assembly and the inner sleeve and having an inner projection member extending downwardly from the top of the outer cover, the outer cover further including a second helical path located on the inner projection member;
rotating the outer cover so the second helical path interacts with the first helical path to rotate and push the spike assembly downwardly into an activated position in which the shaft of the spike assembly perforates the stopper; and
locking the spike assembly in the activated position by a locking mechanism.
31. A kit comprising
the device of claim 1; and
a prefilled diluent syringe.
32-34. (canceled)
35. The device of claim 1, wherein the protrusions are webbed protrusions comprising at least two tabs that grip the neck of the receptacle.
36. The device of claim 1, wherein the actuating mechanism is comprised of
a first helical path located on an outer surface of the spike assembly and a corresponding second helical path located on the inner projection member of the outer cover, such that the first and second helical paths interacting to rotate and push the spike assembly downwardly into the activated position so the shaft of the spike assembly perforates the stopper.
US13/522,481 2010-01-15 2011-01-18 Device Abandoned US20130053814A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US29567910P true 2010-01-15 2010-01-15
PCT/US2011/021580 WO2011088471A1 (en) 2010-01-15 2011-01-18 Device
US13/522,481 US20130053814A1 (en) 2010-01-15 2011-01-18 Device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/522,481 US20130053814A1 (en) 2010-01-15 2011-01-18 Device

Publications (1)

Publication Number Publication Date
US20130053814A1 true US20130053814A1 (en) 2013-02-28

Family

ID=44304701

Family Applications (1)

Application Number Title Priority Date Filing Date
US13/522,481 Abandoned US20130053814A1 (en) 2010-01-15 2011-01-18 Device

Country Status (22)

Country Link
US (1) US20130053814A1 (en)
EP (1) EP2523708A4 (en)
JP (1) JP5829219B2 (en)
KR (1) KR20130008010A (en)
CN (2) CN105193618A (en)
AU (1) AU2011205605A1 (en)
CA (1) CA2787047A1 (en)
CL (1) CL2012001967A1 (en)
CO (1) CO6561800A2 (en)
CR (1) CR20120376A (en)
CU (1) CU20120107A7 (en)
DO (1) DOP2012000200A (en)
EA (1) EA201290626A1 (en)
EC (1) ECSP12012041A (en)
GT (1) GT201200226A (en)
HK (2) HK1219410A1 (en)
IL (1) IL220841D0 (en)
MX (1) MX2012008190A (en)
PE (1) PE08002013A1 (en)
SG (1) SG183104A1 (en)
WO (1) WO2011088471A1 (en)
ZA (1) ZA201205186B (en)

Cited By (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130306509A1 (en) * 2010-09-29 2013-11-21 Norival Caetano Spike-type connector for a medicament reconstitution bag, and safety device for a bottle containing a medicament to be reconstituted
US8608723B2 (en) 2009-11-12 2013-12-17 Medimop Medical Projects Ltd. Fluid transfer devices with sealing arrangement
US8684994B2 (en) 2010-02-24 2014-04-01 Medimop Medical Projects Ltd. Fluid transfer assembly with venting arrangement
US8752598B2 (en) 2011-04-17 2014-06-17 Medimop Medical Projects Ltd. Liquid drug transfer assembly
US8753325B2 (en) 2010-02-24 2014-06-17 Medimop Medical Projects, Ltd. Liquid drug transfer device with vented vial adapter
WO2014152249A1 (en) * 2013-03-14 2014-09-25 Bayer Healthcare Llc Transfer set
US8852145B2 (en) 2010-11-14 2014-10-07 Medimop Medical Projects, Ltd. Inline liquid drug medical device having rotary flow control member
WO2014170888A1 (en) 2013-04-14 2014-10-23 Medimop Medical Projects Ltd Drug container closure for mounting on open-topped drug container to form drug reconstitution assemblage for use with needleless syringe
US8905994B1 (en) 2011-10-11 2014-12-09 Medimop Medical Projects, Ltd. Valve assembly for use with liquid container and drug vial
USD720451S1 (en) 2012-02-13 2014-12-30 Medimop Medical Projects Ltd. Liquid drug transfer assembly
US8979792B2 (en) 2009-11-12 2015-03-17 Medimop Medical Projects Ltd. Inline liquid drug medical devices with linear displaceable sliding flow control member
US8998875B2 (en) 2009-10-01 2015-04-07 Medimop Medical Projects Ltd. Vial assemblage with vial and pre-attached fluid transfer device
USD734868S1 (en) 2012-11-27 2015-07-21 Medimop Medical Projects Ltd. Drug vial adapter with downwardly depending stopper
USD737436S1 (en) 2012-02-13 2015-08-25 Medimop Medical Projects Ltd. Liquid drug reconstitution assembly
US9283324B2 (en) 2012-04-05 2016-03-15 Medimop Medical Projects, Ltd Fluid transfer devices having cartridge port with cartridge ejection arrangement
US9339438B2 (en) 2012-09-13 2016-05-17 Medimop Medical Projects Ltd. Telescopic female drug vial adapter
USD757933S1 (en) 2014-09-11 2016-05-31 Medimop Medical Projects Ltd. Dual vial adapter assemblage
USD765837S1 (en) 2013-08-07 2016-09-06 Medimop Medical Projects Ltd. Liquid transfer device with integral vial adapter
USD767124S1 (en) 2013-08-07 2016-09-20 Medimop Medical Projects Ltd. Liquid transfer device with integral vial adapter
US9662272B2 (en) 2006-04-12 2017-05-30 Icu Medical, Inc. Devices and methods for transferring fluid to or from a vial
US9795536B2 (en) 2012-08-26 2017-10-24 Medimop Medical Projects, Ltd. Liquid drug transfer devices employing manual rotation for dual flow communication step actuations
USD801522S1 (en) 2015-11-09 2017-10-31 Medimop Medical Projects Ltd. Fluid transfer assembly
US9839580B2 (en) 2012-08-26 2017-12-12 Medimop Medical Projects, Ltd. Liquid drug transfer devices
US9931275B2 (en) 2008-08-20 2018-04-03 Icu Medical, Inc. Anti-reflux vial adaptors
US9943463B2 (en) 2013-05-10 2018-04-17 West Pharma. Services IL, Ltd. Medical devices including vial adapter with inline dry drug module
US9987195B2 (en) 2012-01-13 2018-06-05 Icu Medical, Inc. Pressure-regulating vial adaptors and methods
USD832430S1 (en) 2016-11-15 2018-10-30 West Pharma. Services IL, Ltd. Dual vial adapter assemblage
US10117807B2 (en) 2013-01-23 2018-11-06 Icu Medical, Inc. Pressure-regulating devices for transferring medicinal fluid
US10159788B2 (en) 2013-05-01 2018-12-25 Bayer Healthcare Llc Attachment device for medical fluid container
US10201476B2 (en) 2014-06-20 2019-02-12 Icu Medical, Inc. Pressure-regulating vial adaptors
US10251814B2 (en) 2011-02-15 2019-04-09 Cis Pharma Ag Cefuroxime safety delivery system
US10278897B2 (en) 2015-11-25 2019-05-07 West Pharma. Services IL, Ltd. Dual vial adapter assemblage including drug vial adapter with self-sealing access valve
US10285907B2 (en) 2015-01-05 2019-05-14 West Pharma. Services IL, Ltd. Dual vial adapter assemblages with quick release drug vial adapter for ensuring correct usage
US10292904B2 (en) 2016-01-29 2019-05-21 Icu Medical, Inc. Pressure-regulating vial adaptors
US10299989B2 (en) 2012-03-22 2019-05-28 Icu Medical, Inc. Pressure-regulating vial adaptors

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4638553B1 (en) 2010-08-09 2011-02-23 株式会社アルテ Production process and the front stopper dual chamber combined container-syringe
US9480623B2 (en) 2011-10-14 2016-11-01 Novo Nordisk Healthcare Ag Pre-assembled fluid transfer arrangement
CN102716033B (en) * 2012-07-02 2014-10-01 重庆莱美药业股份有限公司 Short process precession prefabricated dosing instrument
US9415885B2 (en) * 2013-03-15 2016-08-16 Dr. Py Institute Llc Device with sliding stopper and related method
DE102015201288B4 (en) 2015-01-26 2017-01-05 Bayer Pharma AG Hollow-needle assembly
DE102015201275A1 (en) 2015-01-26 2016-07-28 Bayer Pharma AG Apparatus for transferring a liquid between a storage vessel and at least one further use container

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675020A (en) * 1985-10-09 1987-06-23 Kendall Mcgaw Laboratories, Inc. Connector
US5496288A (en) * 1992-09-23 1996-03-05 Becton, Dickinson And Company Protective cap for hypodermic syringe
US20070270710A1 (en) * 2003-08-07 2007-11-22 Michael Frass Device Used for Needle Biopsy
US20080091194A1 (en) * 1998-07-07 2008-04-17 Mulier Peter M Helical coil apparatus for ablation of tissue
US20080300570A1 (en) * 1998-09-15 2008-12-04 Baxter International Inc. Reconstitution assembly, locking device and method for a diluent container
US20090216212A1 (en) * 2008-02-18 2009-08-27 Icu Medical, Inc. Vial adaptor
US8562582B2 (en) * 2006-05-25 2013-10-22 Bayer Healthcare Llc Reconstitution device

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6209738B1 (en) * 1998-04-20 2001-04-03 Becton, Dickinson And Company Transfer set for vials and medical containers
FR2783808B1 (en) * 1998-09-24 2000-12-08 Biodome Connecting arrangement between a container and a container together and ready to use such a device comprising
FR2789369B1 (en) * 1999-02-10 2001-04-27 Biodome Connecting arrangement between a container and a container together and ready to use such a device comprising
FR2836129B1 (en) * 2002-02-20 2004-04-02 Biodome Connecting arrangement between a container and a container together and ready to use such a device comprising
WO2005016365A2 (en) * 2003-08-14 2005-02-24 Novo Nordisk Health Care Ag Liquid, aqueous pharmaceutical composition of factor vii polypeptides
FR2894464B1 (en) * 2005-12-14 2008-09-19 Biocorp Rech Et Dev Sa Connection device between two containers operation Secure

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675020A (en) * 1985-10-09 1987-06-23 Kendall Mcgaw Laboratories, Inc. Connector
US5496288A (en) * 1992-09-23 1996-03-05 Becton, Dickinson And Company Protective cap for hypodermic syringe
US20080091194A1 (en) * 1998-07-07 2008-04-17 Mulier Peter M Helical coil apparatus for ablation of tissue
US20080300570A1 (en) * 1998-09-15 2008-12-04 Baxter International Inc. Reconstitution assembly, locking device and method for a diluent container
US20070270710A1 (en) * 2003-08-07 2007-11-22 Michael Frass Device Used for Needle Biopsy
US8562582B2 (en) * 2006-05-25 2013-10-22 Bayer Healthcare Llc Reconstitution device
US20090216212A1 (en) * 2008-02-18 2009-08-27 Icu Medical, Inc. Vial adaptor

Cited By (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10327989B2 (en) 2006-04-12 2019-06-25 Icu Medical, Inc. Devices and methods for transferring fluid to or from a vial
US10022302B2 (en) 2006-04-12 2018-07-17 Icu Medical, Inc. Devices for transferring medicinal fluids to or from a container
US10071020B2 (en) 2006-04-12 2018-09-11 Icu Medical, Inc. Devices for transferring fluid to or from a vial
US9662272B2 (en) 2006-04-12 2017-05-30 Icu Medical, Inc. Devices and methods for transferring fluid to or from a vial
US10327992B2 (en) 2006-04-12 2019-06-25 Icu Medical, Inc. Fluid transfer apparatus with pressure regulation
US10327993B2 (en) 2006-04-12 2019-06-25 Icu Medical, Inc. Vial access devices
US9993391B2 (en) 2006-04-12 2018-06-12 Icu Medical, Inc. Devices and methods for transferring medicinal fluid to or from a container
US10327991B2 (en) 2006-04-12 2019-06-25 Icu Medical, Inc. Fluid transfer apparatus with filtered air input
US9993390B2 (en) 2006-04-12 2018-06-12 Icu Medical, Inc. Pressure-regulating vial adaptors and methods
US9931275B2 (en) 2008-08-20 2018-04-03 Icu Medical, Inc. Anti-reflux vial adaptors
US8998875B2 (en) 2009-10-01 2015-04-07 Medimop Medical Projects Ltd. Vial assemblage with vial and pre-attached fluid transfer device
US8979792B2 (en) 2009-11-12 2015-03-17 Medimop Medical Projects Ltd. Inline liquid drug medical devices with linear displaceable sliding flow control member
US8608723B2 (en) 2009-11-12 2013-12-17 Medimop Medical Projects Ltd. Fluid transfer devices with sealing arrangement
US9132063B2 (en) 2009-11-12 2015-09-15 Medimop Medical Projects Ltd. Inline liquid drug medical devices with linear displaceable sliding flow control member
US8753325B2 (en) 2010-02-24 2014-06-17 Medimop Medical Projects, Ltd. Liquid drug transfer device with vented vial adapter
US8684994B2 (en) 2010-02-24 2014-04-01 Medimop Medical Projects Ltd. Fluid transfer assembly with venting arrangement
US20130306509A1 (en) * 2010-09-29 2013-11-21 Norival Caetano Spike-type connector for a medicament reconstitution bag, and safety device for a bottle containing a medicament to be reconstituted
US9833381B2 (en) * 2010-09-29 2017-12-05 Norival Caetano Spike-type connector for a medicament reconstitution bag, and safety device for a bottle containing a medicament to be reconstituted
US8852145B2 (en) 2010-11-14 2014-10-07 Medimop Medical Projects, Ltd. Inline liquid drug medical device having rotary flow control member
US10251814B2 (en) 2011-02-15 2019-04-09 Cis Pharma Ag Cefuroxime safety delivery system
US8752598B2 (en) 2011-04-17 2014-06-17 Medimop Medical Projects Ltd. Liquid drug transfer assembly
US8905994B1 (en) 2011-10-11 2014-12-09 Medimop Medical Projects, Ltd. Valve assembly for use with liquid container and drug vial
US9987195B2 (en) 2012-01-13 2018-06-05 Icu Medical, Inc. Pressure-regulating vial adaptors and methods
USD720451S1 (en) 2012-02-13 2014-12-30 Medimop Medical Projects Ltd. Liquid drug transfer assembly
USD737436S1 (en) 2012-02-13 2015-08-25 Medimop Medical Projects Ltd. Liquid drug reconstitution assembly
US10299989B2 (en) 2012-03-22 2019-05-28 Icu Medical, Inc. Pressure-regulating vial adaptors
US9283324B2 (en) 2012-04-05 2016-03-15 Medimop Medical Projects, Ltd Fluid transfer devices having cartridge port with cartridge ejection arrangement
US9795536B2 (en) 2012-08-26 2017-10-24 Medimop Medical Projects, Ltd. Liquid drug transfer devices employing manual rotation for dual flow communication step actuations
US9839580B2 (en) 2012-08-26 2017-12-12 Medimop Medical Projects, Ltd. Liquid drug transfer devices
US10299990B2 (en) 2012-08-26 2019-05-28 West Pharma. Services IL, Ltd. Liquid drug transfer devices
US9339438B2 (en) 2012-09-13 2016-05-17 Medimop Medical Projects Ltd. Telescopic female drug vial adapter
USD734868S1 (en) 2012-11-27 2015-07-21 Medimop Medical Projects Ltd. Drug vial adapter with downwardly depending stopper
US10117807B2 (en) 2013-01-23 2018-11-06 Icu Medical, Inc. Pressure-regulating devices for transferring medicinal fluid
EP2968068A4 (en) * 2013-03-14 2016-11-09 Bayer Healthcare Llc Transfer set
WO2014152249A1 (en) * 2013-03-14 2014-09-25 Bayer Healthcare Llc Transfer set
US20160000653A1 (en) * 2013-03-14 2016-01-07 Bayer Healthcare Llc Transfer set
CN105120826A (en) * 2013-04-14 2015-12-02 麦迪麦珀医疗工程有限公司 Drug container closure for mounting on open-topped drug container to form drug reconstitution assemblage for use with needleless syringe
US9801786B2 (en) 2013-04-14 2017-10-31 Medimop Medical Projects Ltd. Drug container closure for mounting on open-topped drug container to form drug reconstitution assemblage for use with needleless syringe
WO2014170888A1 (en) 2013-04-14 2014-10-23 Medimop Medical Projects Ltd Drug container closure for mounting on open-topped drug container to form drug reconstitution assemblage for use with needleless syringe
US10159788B2 (en) 2013-05-01 2018-12-25 Bayer Healthcare Llc Attachment device for medical fluid container
US9943463B2 (en) 2013-05-10 2018-04-17 West Pharma. Services IL, Ltd. Medical devices including vial adapter with inline dry drug module
USD765837S1 (en) 2013-08-07 2016-09-06 Medimop Medical Projects Ltd. Liquid transfer device with integral vial adapter
USD767124S1 (en) 2013-08-07 2016-09-20 Medimop Medical Projects Ltd. Liquid transfer device with integral vial adapter
US10201476B2 (en) 2014-06-20 2019-02-12 Icu Medical, Inc. Pressure-regulating vial adaptors
USD757933S1 (en) 2014-09-11 2016-05-31 Medimop Medical Projects Ltd. Dual vial adapter assemblage
US10285907B2 (en) 2015-01-05 2019-05-14 West Pharma. Services IL, Ltd. Dual vial adapter assemblages with quick release drug vial adapter for ensuring correct usage
USD801522S1 (en) 2015-11-09 2017-10-31 Medimop Medical Projects Ltd. Fluid transfer assembly
US10278897B2 (en) 2015-11-25 2019-05-07 West Pharma. Services IL, Ltd. Dual vial adapter assemblage including drug vial adapter with self-sealing access valve
US10292904B2 (en) 2016-01-29 2019-05-21 Icu Medical, Inc. Pressure-regulating vial adaptors
USD832430S1 (en) 2016-11-15 2018-10-30 West Pharma. Services IL, Ltd. Dual vial adapter assemblage

Also Published As

Publication number Publication date
CA2787047A1 (en) 2011-07-21
EP2523708A4 (en) 2015-02-25
CR20120376A (en) 2013-02-12
ECSP12012041A (en) 2012-08-31
SG183104A1 (en) 2012-09-27
HK1219410A1 (en) 2017-04-07
JP2013517071A (en) 2013-05-16
KR20130008010A (en) 2013-01-21
IL220841D0 (en) 2015-07-30
DOP2012000200A (en) 2013-03-15
EP2523708A1 (en) 2012-11-21
MX2012008190A (en) 2012-08-03
CO6561800A2 (en) 2012-11-15
CN102869397B (en) 2015-10-14
CL2012001967A1 (en) 2013-01-18
GT201200226A (en) 2014-02-12
JP5829219B2 (en) 2015-12-09
AU2011205605A1 (en) 2012-08-02
CU20120107A7 (en) 2012-12-17
CN102869397A (en) 2013-01-09
PE08002013A1 (en) 2013-07-05
ZA201205186B (en) 2013-09-25
EA201290626A1 (en) 2012-12-28
HK1175133A1 (en) 2016-09-30
CN105193618A (en) 2015-12-30
WO2011088471A1 (en) 2011-07-21

Similar Documents

Publication Publication Date Title
EP1033961B1 (en) Fluid transfer device connecting a medicinal vessel and an iv bag in closed system
US6022339A (en) Sliding reconstitution device for a diluent container
CN101437463B (en) Vented safe handling vial adapter
ES2533858T3 (en) Intake assembly intended for a fluid container
EP1703930B1 (en) Positive displacement flush syringe
US9662271B2 (en) Vial adapter and system
US5820621A (en) Medical fluid transfer and delivery device
CN1130238C (en) The medical valve
DK2133059T3 (en) A medical device for liquid medication
US6729370B2 (en) Syringe safety device
EP1858474B1 (en) Filling system and method for syringes with short needles
US9345640B2 (en) Fluid transfer device
JP3294077B2 (en) Injection drug, cold infusion, containers for storage and preparation of diagnostic formulations
US6875203B1 (en) Vial connecting device for a sliding reconstitution device for a diluent container
CN101868273B (en) External drug pumps
JP4599345B2 (en) Drug delivery system and method using the same material
US9526841B2 (en) Spraying device
EP0388457B1 (en) Sliding reconstitution device with seal
US8226627B2 (en) Reconstitution assembly, locking device and method for a diluent container
CA1239619A (en) Reconstitution device
US5695463A (en) Safety injection device
US5391150A (en) IV bag with needleless connector ports
EP0465632B1 (en) Integral reconstitution device
CN101969914B (en) Vial adapter element
EP0832659B1 (en) A lockable safety shield for a prefillable syringe

Legal Events

Date Code Title Description
AS Assignment

Owner name: BAYER HEALTHCARE LLC, NEW YORK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MUELLER-BECKHAUS, ANDREAS;PROSISE, KEVIN;CHENG, EDWARD;AND OTHERS;SIGNING DATES FROM 20121002 TO 20121015;REEL/FRAME:029283/0552

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION